Have a personal or library account? Click to login
Role of Fusobacterium Nucleatum and Porphyromonas Gingivalis in Oral Cancer: A Literature Review Cover

Role of Fusobacterium Nucleatum and Porphyromonas Gingivalis in Oral Cancer: A Literature Review

Open Access
|Jul 2025

References

  1. Abdulkareem AA, Shelton RM, Landini G, Cooper PR, Milward MR.: Periodontal pathogens promote epithelial-mesenchymal transition in oral squamous carcinoma cells in vitro. Cell Adhesion & Migration, 12(2), 127–137 (2018) DOI: 10.1080/19336918.2017.1322253
  2. Ahmadi P, Mahmoudi M, Kheder RK, Faraj TA, Mollazadeh S, Abdulabbas HS, Esmaeili SA: Impacts of Porphyromonas gingivalis periodontitis on rheumatoid arthritis autoimmunity. International Immunopharmacology, 118, 109936–109936 (2023) DOI: 10.1016/j.intimp.2023.109936
  3. Al-hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T, Idris AM, Johnson NW.: Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Scientific Reports, 7(1), 1834 (2017) DOI: 10.1038/s41598-017-02079-3
  4. Aral K, Milward MR, Gupta D, Cooper PR.: Effects of Porphyromonas gingivalis and Fusobacterium nucleatum on inflammasomes and their regulators in H400 cells. Molecular Oral Microbiology, 35(4), 158–167 (2020) DOI: 10.1111/omi.12302
  5. Bi R, Yang Y, Liao H, Ji G, Ma Y, Cai L, Li J, Yang J, Sun M, Liang J, et al.: Porphyromonas gingivalis induces an inflammatory response via the cGAS-STING signaling pathway in a periodontitis mouse model. Frontiers in microbiology, 14, 1183415 (2023) DOI: 10.3389/fmicb.2023.1183415
  6. Bolstad AI, Jensen HB, Bakken V.: Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clinical Microbiology Reviews, 9(1), 55–71 (1996) DOI: 10.1128/cmr.9.1.55
  7. Cai L, Zhu H, Mou Q, Wong PY, Lan L, Ng C, Lei P, Cheung MK, Wang D, Wong E, et al.: Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma. npj biofilms and microbiomes, 10(1) (2024) DOI: 10.1038/s41522-024-00511-x
  8. Chang C, Geng F, Shi X, Li Y, Zhang X, Zhao X, Pan Y.: The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma. Applied microbiology and biotechnology, 103(3), 1393–1404 (2018) DOI: 10.1007/s00253-018-9475-6
  9. Chen G, Gao C, Jiang S, Cai Q, Li R, Sun Q, Xiao C, Xu Y, Wu B, Zhou H.: Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis. Journal of Advanced Research, 56, 167–179 (2024) DOI: 10.1016/j. jare.2023.04.002
  10. Chen Q, Shao Z, Liu K, Zhou X, Wang L, Jiang E, Luo T, Shang Z.: Salivary Porphyromonas gingivalis predicts outcome in oral squamous cell carcinomas: a cohort study. BMC Oral Health, 21(1) (2021) DOI: 10.1186/s12903-021-01580-6
  11. Chen Y, Huang Z, Tang Z, Huang Y, Huang M, Liu H, Ziebolz D, Schmalz G, Jia B, Zhao J.: More than just a periodontal pathogen – the research progress on Fusobacterium nucleatum. Frontiers in Cellular and Infection Microbiology, 12 (2022) DOI: 10.3389/fcimb.2022.815318
  12. Chen Y, Shi T, Li Y, Huang L, Yin D.: Fusobacterium nucleatum: The opportunistic pathogen of periodontal and peri-implant diseases. Frontiers in Microbiology, 13 (2022) DOI: 10.3389/fmicb.2022.860149
  13. Chen Z, Wong PY, Ng CWK, Lan L, Fung S, Li JW, Cai L, Lei P, Mou Q, Wong SH, et al.: The intersection between oral microbiota, host gene methylation and patient outcomes in head and neck squamous cell carcinoma. Cancers, 12(11) 3425 (2020) DOI: 10.3390/cancers12113425
  14. Cho TJ, Wee SW, Woo VH, Choi JI, Kim SJ, Shin HI, Lee JH, Park HR.: Porphyromonas gingivalis-induced autophagy suppresses cell proliferation through G1 arrest in oral cancer cells. Archives of Oral Biology, 59(4), 370–378 (2014) DOI: 10.1016/j. archoralbio.2014.01.001
  15. Conrads G, Klomp T, Deng D, Wenzler J-S, Braun A, Abdelbary MMH.: The antimicrobial susceptibility of Porphyromonas gingivalis: genetic repertoire, global phenotype, and review of the literature. Antibiotics, 10(12), 1438–1438 (2021) DOI: 10.3390/antibiotics10121438
  16. Da J, Wang X, Li L, Xu Y.: Fusobacterium nucleatum promotes cisplatin-resistance and migration of oral squamous carcinoma cells by up-regulating Wnt5a-Mediated NFATc3 expression. Tohoku Journal of Experimental Medicine, 253(4) 249–259 (2021) DOI: 10.1620/tjem.253.249
  17. Dahlstrand Rudin A, Khamzeh A, Venkatakrishnan V, Basic A, Christenson K, Bylund J.: Short chain fatty acids released by Fusobacterium nucleatum are neutrophil chemoattractants acting via free fatty acid receptor 2 (FFAR2). Cellular Microbiology, 23(8) (2021) DOI: 10.1111/cmi.13348
  18. Fan Z, Tang P, Li C, Yang Q, Xu Y, Su C, Li L.: Fusobacterium nucleatum and its associated systemic diseases: epidemiologic studies and possible mechanisms. Journal of Oral Microbiology, 15(1) (2022) DOI: 10.1080/20002297.2022.2145729
  19. Fernandes B, Jose Guilherme Datorre, Vazquez F, Peters A, Fabio Luiz Coracin, Reis R, Arantes L, Gama R.: Association of Fusobacterium nucleatum levels by ddPCR in oral rinse samples with periodontal disease in oral squamous cell carcinoma patients and in controls. J Oral Pathol Med. 53(10), 657-666 (2024) DOI: 10.1111/jop.13580
  20. Galasso L & Zocco M, et al.: Unraveling the role of Fusobacterium nucleatum in colorectal cancer: molecular mechanisms and pathogenic insights. Cancers, 17(3), 368 (2025) DOI: 10.3390/cancers17030368
  21. Gallimidi AB, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, Nussbaum G, Elkin M.: Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget, 6(26) 22613–22623 (2015) DOI: 10.18632/oncotarget.4209
  22. Ganly I, Yang L, Giese RA, Hao Y, Nossa CW, Morris LGT, Rosenthal M, Migliacci J, Kelly D, Tseng W, et al.: Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. International Journal of Cancer, 145(3), 775–784 (2019) DOI: 10.1002/ijc.32152
  23. Geng F, Zhang Y, Lu Z, Zhang S, Pan Y.: Fusobacterium nucleatum caused DNA damage and promoted cell proliferation by the Ku70/p53 pathway in oral cancer cells. DNA and Cell Biology, 39(1), 144–151 (2020) DOI: 10.1089/dna.2019.5064
  24. Groeger S, Denter F, G. Lochnit, Schmitz ML, Meyle J.: Porphyromonas gingivalis cell wall components induce programmed death ligand 1 (PD-L1) expression on human oral carcinoma cells by a receptor-interacting protein kinase 2 (RIP2)-dependent mechanism. Infection and Immunity, 88(5), e00051-20 (2020) DOI: 10.1128/iai.00051-20
  25. Groeger S, Herrmann JM, Chakraborty T, Domann E, Ruf S, Meyle J.: Porphyromonas gingivalis W83 membrane components induce distinct profiles of metabolic genes in oral squamous carcinoma cells. International Journal of Molecular Sciences, 23(7), 3442 (2022) DOI: 10.3390/ijms23073442
  26. Groeger S, Jarzina F, Domann E, Meyle J.: Porphyromonas gingivalis activates NFκB and MAPK pathways in human oral epithelial cells. BMC Immunology, 18(1) (2017) DOI: 10.1186/s12865-016-0185-5
  27. Guo Z, Jing S, Jia X, Elayah SA, Xie L, Cui H, Tu J, Na S.: Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by stimulating the release of neutrophil extracellular traps in the tumor immune microenvironment. Inflammation Research, 73(5), 693–705 (2023) DOI: 10.1007/s00011-023-01822-z
  28. Guo Z, Jing S, Jumatai S, Gong Z.: Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment. Cancer Immunology Immunotherapy, 72(6), 1523– 1539 (2022) DOI: 10.1007/s00262-022-03348-5
  29. Gur C, Maalouf N, Shhadeh A, Berhani O, Singer BB, Bachrach G, Mandelboim O.: Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. Onco Immunology, 8(6), e1581531–e1581531 (2019) DOI: 10.1080/2162402x.2019.1581531
  30. Ha NH, Park DG, Woo BH, Kim DJ, Choi J, Park BS, Kim YD, Lee JH, Park HR.: Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs. Cytokine, 86, 64–72 (2016) DOI: 10.1016/j.cyto.2016.07.013
  31. Ha NH, Woo BH, Kim DJ, Ha ES, Choi JI, Kim SJ, Park BS, Lee JH, Park HR: Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties. Tumor Biology, 36(12), 9947–9960 (2015) DOI: 10.1007/s13277-015-3764-9
  32. Hahnke RL, Meier-Kolthoff JP, García-López M, Mukherjee S, Huntemann M, Ivanova NN, Woyke T, Kyrpides NC, Klenk H-P, Göker M.: Corrigendum: Genome-based taxonomic classification of Bacteroidetes. Frontiers in Microbiology, 9, 304 (2018) DOI: 10.3389/fmicb.2018.00304
  33. Harrandah AM, Chukkapalli SS, Bhattacharyya I, Progulske-Fox A, Chan EKL.: Fusobacteria modulate oral carcinogenesis and promote cancer progression. Journal of Oral Microbiology, 13(1) (2020) DOI: 10.1080/20002297.2020.1849493
  34. He X, Ma X, Meng Z, Han Z, Chen W.: Localization of Fusobacterium nucleatum in oral squamous cell carcinoma and its possible directly interacting protein molecules: A case series. Histology and histopathology, 38(8), 929–939 (2023) DOI: 10.14670/hh-18-560
  35. Hooper SJ, Crean SJ, Lewis MAO, Spratt DA, Wade WG, Wilson MJ.: Viable bacteria present within oral squamous cell carcinoma tissue. Journal of Clinical Microbiology, 44(5), 1719–1725 (2006) DOI: 10.1128/jcm.44.5.1719-1725.2006
  36. Horvat Aleksijević L, Aleksijević M, Škrlec I, Šram M, Šram M, Talapko J.: Porphyromonas gingivalis virulence factors and clinical significance in periodontal disease and coronary artery diseases. Pathogens, 11(10), 1173 (2022) DOI: 10.3390/patho-gens11101173
  37. How KY, Song KP, Chan KG.: Porphyromonas gingivalis: An overview of periodontopathic pathogen below the gum line. Frontiers in Microbiology 7(53) (2016) DOI: 10.3389/fmicb.2016.00053
  38. Inaba H, Sugita H, Kuboniwa M, Iwai S, Hamada M, Noda T, Morisaki I, Lamont RJ, Amano A.: Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cellular Microbiology, 16(1), 131–145 (2013) DOI: 10.1111/cmi.12211
  39. Jia L, Han N, Du J, Guo L, Luo Z, Liu Y.: Pathogenesis of important virulence factors of Porphyromonas gingivalis via Toll-Like Receptors. Frontiers in Cellular and Infection Microbiology, 9 (2019) DOI: 10.3389/fcimb.2019.00262
  40. Kamarajan P, Ateia I, Shin JM, Fenno JC, Le C, Zhan L, Chang A, Darveau R, Kapila YL.: Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin. Tsolis RM, editor. PLOS Pathogens, 16(10), e1008881 (2020) DOI: 10.1371/journal.ppat.1008881
  41. Kanagasingam S, Chukkapalli SS, Welbury R, Singhrao SK.: Porphyromonas gingivalis is a strong risk factor for Alzheimer’s disease. Journal of Alzheimer’s Disease Reports, 4(1), 501–511 (2020) DOI: 10.3233/ADR-200250
  42. Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S.: Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. International Journal of Oral Science, 3(4), 209–215 (2011) DOI: 10.4248/ijos11075
  43. Kuper H, Adami H-O., Trichopoulos D.: Infections as a major preventable cause of human cancer. Journal of Internal Medicine, 249(S741), 61–74 (2001) DOI: 10.1046/j.1365-2796.2001.00742.x
  44. Lamont RJ, Jenkinson HF.: Subgingival colonization by Porphyromonas gingivalis. Oral Microbiology and Immunology, 15(6), 341–349 (2000) DOI: 10.1034/j.1399-302x.2000.150601.x
  45. Lan Z, Zou K, Cui H, Zhao Y, Yu G.: Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment. Molecular Oncology, 18(5), 1174–1188 (2023) DOI: 10.1002/1878-0261.13517
  46. Laprise C, Shahul HP, Madathil SA, Thekkepurakkal AS, Castonguay G, Varghese I, Shiraz S, Allison P, Schlecht NF, Rousseau M-C, et al.: Periodontal diseases and risk of oral cancer in Southern India: Results from the HeNCe Life study. International Journal of Cancer, 139(7), 1512–1519 (2016) DOI: 10.1002/ijc.30201
  47. Li C, Li M, Wei W, Wang Z, Yu J, Gong Z.: Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China. BMC Cancer, 24(1), 534 (2024) DOI: 10.1186/s12885-024-12300-y
  48. Li Z, Liu Y, Huang X, Wang Q, Fu R, Wen X, Liu J, Zhang L.: F. Nucleatum enhances oral squamous cell carcinoma proliferation via E-cadherin/β-Catenin pathway. BMC oral health, 24(1), (2024) DOI: 10.1186/s12903-024-04252-3
  49. Liu D, Liu S, Liu J, Miao L, Zhang S, Pan Y.: sRNA23392 packaged by Porphyromonas gingivalis outer membrane vesicles promotes oral squamous cell carcinomas migration and invasion by targeting desmocollin‐2. Molecular oral microbiology, 36(3), 182–191 (2021) DOI: 10.1111/omi.12334
  50. Liu S, Zhou X, Peng X, Li M, Ren B, Cheng G, Cheng L.: Porphyromonas gingivalis promotes immunoevasion of oral cancer by protecting cancer from macrophage attack. The Journal of Immunology, 205(1), 282–289 (2020) DOI: 10.4049/jimmunol.1901138
  51. Lu Z, Cao R, Geng F, Pan Y.: Persistent infection with Porphyromonas gingivalis increases the tumorigenic potential of human immortalised oral epithelial cells through ZFP36 inhibition. Cell Proliferation, 57(6), (2024) DOI: 10.1111/cpr.13609
  52. Ma Z, Bi Q, Wang Y.: Hydrogen sulfide accelerates cell cycle progression in oral squamous cell carcinoma cell lines. Oral Diseases, 21(2), 156–162 (2014) DOI: 10.1111/odi.12223
  53. Min J, Mashimo C, Nambu T, Maruyama H, Takigawa H, Okinaga T.: Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum. Archives of oral biology, 160, 105897 (2024) DOI: 10.1016/j.archoralbio.2024.105897
  54. Moraes SR, Siqueira JF, Rôças IN, Ferreira MCS, Domingues RMCP.: Clonality of Fusobacterium nucleatum in root canal infections. Oral Microbiology and Immunology, 17(6), 394–396 (2002) DOI: 10.1034/j.1399-302x.2002.170610.x
  55. Muraoka A & Kondo Y et al. Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts. Science Translational Medicine, 15(700) (2023) DOI: 10.1126/scitranslmed.add1531
  56. Nagy KN, Sonkodi I, Szöke I, Nagy E, Newman HN.: The microflora associated with human oral carcinomas. Oral Oncology, 34(4), 304–308 (1998) DOI: 10.1016/s1368-8375(98)80012-2
  57. Nakano S, Kasai M, Nakamura K, Akasaka T, Yoshida Y, Suzuki S, Ohiro Y, Hasebe A.: Epithelial-mesenchymal transition in oral cancer cells induced by prolonged and persistent Fusobacterium nucleatum stimulation. Journal of oral biosciences, 66(3), 594–604 (2024) DOI: 10.1016/j.job.2024.05.006
  58. Neuzillet C, Marchais M, Vacher S, Hilmi M, Schnitzler A, Meseure D, Leclere R, Lecerf C, Dubot C, Jeannot E, et al.: Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients. Scientific Reports, 11(1) (2021) DOI: 10.1038/s41598-021-86816-9
  59. Nie F, Zhang J, Tian H, Zhao J, Gong P, Wang H, Wang S, Yang P, Yang C.: The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression. Cell death and disease, 15(4) (2024) DOI: 10.1038/s41419-024-06640-7
  60. Pang X, Li J, Liu Z, Chen Q, Chen W-H, Zhang X-Z, Luo G-F, Shang Z.: Targeted elimination of the oral pathogen to overcome chemoresistance of oral squamous cell carcinoma by biologically derived nanotherapeutics. ACS Nano, 18(46), 31794– 31808 (2024) DOI: 10.1021/acsnano.4c07000
  61. Park D-G, Woo BH, Lee B-J, Yoon S, Cho Y, Kim Y-D, Park HR, Song JM.: Serum levels of interleukin-6 and titers of antibodies against Porphyromonas gingivalis could be potential biomarkers for the diagnosis of oral squamous cell carcinoma. International Journal of Molecular Sciences, 20(11), 2749 (2019) DOI: 10.3390/ijms20112749
  62. Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B, Li X, Saxena D.: Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiology, 12(1) (2012) DOI: 10.1186/1471-218012-144
  63. Rui M, Zhang X, Huang J, Wei D, Li Z, Shao Z, Ju H, Ren G.: The baseline oral microbiota predicts the response of locally advanced oral squamous cell carcinoma patients to induction chemotherapy: A prospective longitudinal study. Radiotherapy and Oncology, 164, 83–91 (2021) DOI: 10.1016/j. radonc.2021.09.013
  64. Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz ELS, Nightingale K, Kerr AR, DeLacure MD, Veeramachaneni R, et al.: Changes in abundance of oral microbiota associated with oral cancer. PLoS ONE, 9(6), e98741 (2014) DOI: 10.1371/journal.pone.0098741
  65. Selvaraj A, McManus G, Healy CM, Moran GP.: Fusobacterium nucleatum induces invasive growth and angiogenic responses in malignant oral keratinocytes that are cell line-and bacterial strain-specific. Frontiers in Cellular and Infection Microbiology, 14, 1417946 (2024) DOI: 10.3389/fcimb.2024.1417946
  66. Shah HN, Collins MD.: Proposal for reclassification of Bacteroides asaccharolyticus, Bacteroides gingivalis, and Bacteroides endodontalis in a new genus, Porphyromonas. International Journal of Systematic and Evolutionary Microbiology, 38(1), 128–131 (1988) DOI: 10.1099/00207713-38-1-128
  67. Shao W, Fujiwara N, Mouri Y, Kisoda S, Yoshida K, Yoshida K, Yumoto H, Ozaki K, Ishimaru N, Kudo Y.: Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells. Scientific Reports, 11(1) (2021) DOI: 10.1038/s41598-021-94384-1
  68. Shridhar K, Aggarwal A, Rawal I, Gupta R, Masih S, Mehrotra R, Gillespie TW, Dhillon PK, Michaud DS, Prabhakaran D, et al.: Feasibility of investigating the association between bacterial pathogens and oral leukoplakia in low and middle income countries: A population-based pilot study in India. PloS one, 16(4), e0251017–e0251017 (2021) DOI: 10.1371/journal. pone.0251017
  69. Singh A, Wyant T, Anaya-Bergman C, Aduse-Opoku J, Brunner J, Laine ML, Curtis MA, Lewis JP.: The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Infection and Immunity, 79(11), 4533–4542 (2011) DOI: 10.1128/IAI.05016-11
  70. Singh S, Yadav PK, Singh AK.: Structure based High-Throughput Virtual Screening, Molecular Docking and Molecular Dynamics Study of anticancer natural compounds against fimbriae (FimA) protein of Porphyromonas gingivalis in oral squamous cell carcinoma. Molecular Diversity, 28(3), 1141–1152 (2023) DOI: 10.1007/s11030-023-10643-5
  71. Su S-C, Chang L-C, Huang H-D, Peng C-Y, Chuang C-Y, Chen Y-T, Lu M-Y, Chiu Y-W, Chen P-Y, Yang S-F.: Oral microbial dysbiosis and its performance in predicting oral cancer. Carcinogenesis, 42(1), 127–135 (2021) DOI: 10.1093/carcin/bgaa062
  72. Sztukowska MN, Ojo A, Ahmed S, Carenbauer AL, Wang Q, Shumway B, Jenkinson HF, Wang H, Darling DS, Lamont RJ.: Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells. Cellular Microbiology, 18(6), 844–858 (2016) DOI: 10.1111/cmi.12554
  73. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR, Rigual NR, Merzianu M, Hauck L, et al.: Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiology Biomarkers & Prevention, 18(9), 2406–2412 (2009) DOI: 10.1158/1055-9965.epi-09-0334
  74. Uitto V-J, Baillie D, Wu Q, Gendron R, Grenier D, Putnins EE, Kanervo A, Firth JD.: Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infection and Immunity, 73(2), 1171–1179 (2005) DOI: 10.1128/iai.73.2.1171-1179.2005
  75. Wang P-L, Ohura K.: Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Critical reviews in oral biology and medicine: an official publication of the American Association of Oral Biologists, 13(2), 132–42 (2002) DOI: 10.1177/154411130201300204
  76. Wang X, Buhimschi CS, Temoin S, Bhandari V, Han YW, Buhimschi IA.: Comparative microbial analysis of paired amniotic fluid and cord blood from pregnancies complicated by preterm birth and early-onset neonatal sepsis. PloS One, 8(2), e56131 (2013) DOI: 10.1371/journal.pone.0056131
  77. Wang Y, Wang L, Sun T, Shen S, Li Z, Ma X, Gu X, Zhang X, Peng A, Xu X, et al.: Study of the inflammatory activating process in the early stage of Fusobacterium nucleatum infected PDLSCs. International Journal of Oral Science, 15(1) (2023) DOI: 10.1038/s41368-022-00213-0
  78. Warnakulasuriya S & Johnson, N.W. et al.: Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Diseases, 27(8) (2020) DOI: 10.1111/odi.13704
  79. Wen L, Mu W, Lu H, Wang X, Fang J, Jia Y, Li Q, Wang D, Wen S, Guo J, et al.: Porphyromonas gingivalis promotes oral squamous cell carcinoma progression in an immune microenvironment. Journal of Dental Research, 99(6), 666–675 (2020) DOI: 10.1177/0022034520909312
  80. Woo BH, Kim DJ, Choi JI, Kim SJ, Park BS, Song JM, Lee JH, Park HR.: Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential. Oncotarget, 8(29), 46981–46992 (2017) DOI: 10.18632/oncotarget.16550
  81. Xie M, Tang Q, Yu S, Sun J, Mei F, Zhao J, Chen L.: Porphyromonas gingivalis disrupts vascular endothelial homeostasis in a TLR-NF-κB axis dependent manner. International Journal of Oral Science, 12(1) (2020) DOI: 10.1038/s41368-020-00096-z
  82. Yang C-Y, Yeh Y-M, Yu H-Y, Chin C-Y, Hsu C-W, Liu H, Huang P-J, Hu S-N, Liao C-T, Chang K-P, et al.: Oral microbiota community dynamics associated with oral squamous cell carcinoma staging. Frontiers in Microbiology, 9 (2018) DOI: 10.3389/fmicb.2018.00862
  83. Zhang L, Liu Y, Zheng HJ, Zhang CP.: The oral microbiota may have influence on oral cancer. Frontiers in Cellular and Infection Microbiology, 9 (2020) DOI: 10.3389/fcimb.2019.00476
  84. Zhang S, Bian H, Li X, Wu H, Bi Q, Yan Y, Wang Y.: Hydrogen sulfide promotes cell proliferation of oral cancer through activation of the COX2/AKT/ERK1/2 axis. Oncology Reports, 35(5), 2825–2832 (2016) DOI: 10.3892/or.2016.4691
  85. Zhang S, Li C, Liu J, Geng F, Shi X, Li Q, Lu Z, Pan Y.: Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway. The FEBS Journal, 287(18), 4032–4047 (2020) DOI: 10.1111/febs.15233
  86. Zhang S, Li C, Zhang Z, Li Y, Li Q, Geng F, Liu J, Pan Y.: Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer. Journal of Cellular and Molecular Medicine, 25(2), 892–904 (2021) DOI: 10.1111/jcmm.16142
DOI: https://doi.org/10.2478/am-2025-0005 | Journal eISSN: 2545-3149 | Journal ISSN: 0079-4252
Language: English, Polish
Page range: 51 - 62
Submitted on: Apr 14, 2025
|
Accepted on: Jun 17, 2025
|
Published on: Jul 8, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Urszula Durlak, Wiktor Szczuciński, Zuzanna Wyleciał, Julia Ząber, Paweł Krzyściak, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.